Solventum Corp (SOLV) income statement
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.48+0.42 (+0.49%)
Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –
Solventum Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 54.8%
- Operating margin
- 5.6%
- Net margin
- 1.9%
- Return on equity, FY2025
- 38.9%
Financial strength
- Current ratio
- 1.03
- Debt to equity
- 1.05
- Debt to assets
- 35.8%
- Cash to current liabilities
- 12.6%
Valuation
- P/E ratio
- 97.2
- Price to sales
- 1.80
- Price to book
- 3.06
- Dividend yield
- –
See a number that looks wrong?